Samsung Display recently acquired a license from the US Commerce Department to export some of its smartphone OLED displays to Huawei.
Samsung Display is the world's largest smartphone OLED display supplier.
The US started imposing bans on the supply of components made with American equipment, software, and design to Huawei without their prior approval on Sept. 15, citing national security reasons.
Samsung Display is the first South Korean company to earn such approval from the US after Washington's restrictions against Huawei went into effect.
Insiders say that a license may have been granted to Samsung Display as display panels are less sensitive products than semiconductors, which may be why chipmakers Samsung Electronics Co. and SK hynix Inc. have yet to receive theirs from the US authorities.
However, LG Display Co. has so far not received its export license.
But with Huawei struggling to get memory chips from major suppliers, it is doubtful whether it would increase its display procurement.
An official of a local electronics firm noted that without chip supplies Huawei can't make smartphones.


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Washington Post Publisher Will Lewis Steps Down After Layoffs
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



